Cytokines and Janus kinase/signal transducer and activator of transcription signaling in prostate cancer: overview and therapeutic opportunities
Authors:
- Giacomo CanesinGCGiacomo Canesin
- Agnieszka KrzyzanowskaAKAgnieszka Krzyzanowska
- Rebecka HellstenRHRebecka Hellsten
- Anders BjartellABAnders Bjartell
Open Access
- 1 February 2020
- journal article
- Published by Elsevier in Current Opinion in Endocrine and Metabolic Research
- Vol. 10, 36-42
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- The regulation of JAKs in cytokine signaling and its breakdown in diseaseCytokine, 2019
- High-Fat Diet-Induced Inflammation Accelerates Prostate Cancer Growth via IL6 SignalingClinical Cancer Research, 2018
- Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibitionMolecular and Cellular Endocrinology, 2017
- A Paracrine Role for IL6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor CellsCancer Immunology Research, 2015
- The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate CancerCancers, 2014
- Improved Prediction of Disease Relapse after Radical Prostatectomy through a Panel of Preoperative Blood-Based BiomarkersClinical Cancer Research, 2008
- Principles of interleukin (IL)-6-type cytokine signalling and its regulationBiochemical Journal, 2003
- Interleukin-6 Is an Autocrine Growth Factor in Human Prostate CancerThe American Journal of Pathology, 2001
- Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasisUrology, 2001
- Interleukin-6: A candidate mediator of human prostate cancer morbidityUrology, 1995